The Institute of Human Virology at the University of Maryland School of Medicine received a $14.4 million grant for HIV research.
The grant, awarded by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), will fund research aimed at tackling a significant scientific challenge in HIV vaccine research – the inability to produce long-lasting antibodies to protect against the infection.